Biosimilars and Follow-On Biologics 2018 Americas is a conference that covers topics such as:
- Clinical and preclinical challenges in the development of biosimilars
- Global regulations and guidelines for Biosimilars including variations and new developments
- Conducting trials, assessing immunogenicity and pharmacovigilance
- Challenges encountered with specific product manufacturing
- Issues in developing biosimilars mAbs
- CMC requirements in order to produce high quality similar biologic product
- How the BRIC market is dealing with Biosimilars
Biosimilars and Follow-On Biologics 2018 Americas brings together Directors, VPs, Managers and Heads from:
- Follow on Biologics/Follow on Proteins/Biosimilars
- Biologics/Biotechnology/ Biogenerics
- Biopharmaceuticals/ Biotherapeutics
- Legal Affairs
- Intellectual property
- Pricing and Reimbursement
- Clinical Immunology
- Regulatory Compliance
- R & D
- Preclinical and Clinical Development
- New Product Development
- Quality Affairs/ Quality Control
- Principal Scientist
- Pharmacovigilance
- Chief Scientific Officer
- Drug Safety & Risk Management
- Health Economics
- Process Control and Analytical Technologies
- Business Development
- Commercial Affairs
- Marketing & sales
- Intellectual Property
- Legislation and Policy Advice
- Business Development
- Licensing
- Manufacturing
- APIs
- Bioequivalence
- Drug and Safety Assessment
- Market Strategy
- Regulatory Affairs